Overexpression of activated nuclear factor-kappa B in aorta of patients with coronary atherosclerosis
- PMID: 20014193
- PMCID: PMC6652953
- DOI: 10.1002/clc.20482
Overexpression of activated nuclear factor-kappa B in aorta of patients with coronary atherosclerosis
Abstract
Background: Inflammation is an established risk factor for atherosclerosis. In an inflammatory state, nuclear factor-kappa B (NF-kappaB) is frequently activated as a key transcription activator for the downstream responses.
Hypothesis: The aim of this study was to investigate the changes of NF-kappaB in the aorta of patients with coronary atherosclerosis and its association with atherosclerotic risk factors.
Methods: From 2004 to 2005, we collected a small piece of ascending aorta in the bypass procedure from patients (n = 31) undergoing coronary artery bypass graft (CABG) surgery. The expression of NF-kappaB was determined by immunohistochemistry, and its transcriptional activity was evaluated by electrophoretic mobility shift assay. Celiac aortic tissues from 4 subjects without known atherosclerosis through the kidney donation program were taken as control.
Results: NF-kappaB was detectable in aortas from CABG patients with the transcriptional activities significantly increased. The relative level of aortic NF-kappaB expression was elevated in patients who were smokers or with hypertension. Spearman correlation revealed that aortic NF-kappaB expression had significant correlation with coronary severity scores (Gensini score, r = 0.608, P < .05). The NF-kappaB expression was positively correlated with the levels of blood glucose, low-density lipoprotein cholesterol, lipoprotein(a), total cholesterol, and non-high-density lipoprotein cholesterol (P < .05); but negatively correlated with high-density lipoprotein cholesterol (P < .05).
Conclusions: Our study demonstrates a highly activated NF-kappaB in aortas from patients with coronary atherosclerosis, which may reflect overall arterial overinflammatory status. The findings of hyperactive NF-kappaB in aortas may provide a diagnostic parameter for the inflammation that is associated with and may cause atherosclerosis.
Copyright 2009 Wiley Periodicals, Inc.
References
-
- Ross R. Atherosclerosis—an inflammatory disease. N Engl J Med 1999; 340(2): 115–126. - PubMed
-
- de Winther MP, Kanters E, Kraal G, Hofker MH. Nuclear factor kappaB signaling in atherogenesis. Arterioscler Thromb Vasc Biol 2005; 25(5): 904–914. - PubMed
-
- World Medical Association declaration of Helsinki: Recommendations guiding physicians in biomedical research involving human subjects. JAMA 1997; 277(11): 925–926. - PubMed
-
- Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 1983; 51(3): 606. - PubMed
-
- Wilson SH, Best PJ, Edwards WD, et al Nuclear factor‐kappa B immunoreactivity is present in human coronary plaque and enhanced in patients with unstable angina pectoris. Atherosclerosis 2002; 160(1): 147–153. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
